Literature DB >> 841669

Clinical value of washed-platelet concentrates in patients with non-hemolytic transfusion reactions.

A J Silvergleid, E B Hafleigh, M A Harabin, R M Wolf, F C Grumet.   

Abstract

In patients with severe allergic reactions to plasma proteins it is possible to observe such reactions to even the small quantity of plasma contained in platelet concentrates. A platelet washing solution was designed, and platelet concentrates for four such patients were washed before infusion. Transfusion reactions were completely eliminated by the washing procedure. Platelet recovery was equivalent to that of unwashed platelets, and hemostatic effectiveness of the infused platelet concentrates was evidenced by abrupt cessation of bleeding episodes, including purpura and hematuria. Platelet washing represents a valuable, rapid and simple approach to the problem patient with thrombocytopenia and severe reactions to plasma proteins.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 841669     DOI: 10.1046/j.1537-2995.1977.17177128881.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  4 in total

Review 1.  Scratching the surface of allergic transfusion reactions.

Authors:  William J Savage; Aaron A R Tobian; Jessica H Savage; Robert A Wood; John T Schroeder; Paul M Ness
Journal:  Transfusion       Date:  2012-09-24       Impact factor: 3.157

2.  Storage of reagent platelets for anti-platelet antibody testing in the 51Cr platelet lysis assay.

Authors:  G E Lizak; F C Grumet
Journal:  J Clin Pathol       Date:  1979-02       Impact factor: 3.411

3.  The impact of apheresis platelet manipulation on corrected count increment.

Authors:  Matthew Karafin; Alice K Fuller; William J Savage; Karen E King; Paul M Ness; Aaron A R Tobian
Journal:  Transfusion       Date:  2012-01-10       Impact factor: 3.157

Review 4.  Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment.

Authors:  Fumiya Hirayama
Journal:  Br J Haematol       Date:  2012-12-06       Impact factor: 6.998

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.